AI-generated summary
The authors report on a repeated topical bleaching protocol for melasma in 163 patients and a combined topical and Q-switched ruby laser protocol for acquired dermal melanocytosis in 62 patients, each given 1 to 3 times. They found that clinical clearance of pigmentation was significantly correlated with the number of sessions for both conditions. The authors also suggest that epidermal and dermal pigmentation may be treated separately in dark-skinned people.
- Who or what was studied
- Patients with melasma (n=163) and acquired dermal melanocytosis (n=62), with the abstract noting these conditions are most common in women with darker skin.
- Limits stated in the abstract
- The abstract does not describe a control group or randomization, and it reports correlations with session number rather than comparative outcome data against conventional treatment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Inflammation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.